Literature DB >> 16340532

Short-term inter-visit variability of erg amplitudes in normal subjects and patients with retinitis pigmentosa.

Gerald A Fishman1, Aimee V Chappelow, Robert J Anderson, Ygal Rotenstreich, Deborah J Derlacki.   

Abstract

PURPOSE: To evaluate the short-term test/retest variability in visually normal subjects and patients with retinitis pigmentosa (RP), and to assess the effect of stimulus intensity and baseline amplitude on electroretinogram (ERG) variability.
METHODS: Eighteen patients with RP and nine visually normal subjects had a series of three unilateral ERGs, with an inter-visit interval of no less than 2 days and no more than 2 weeks. Responses to dark-adapted and both light-adapted single flash and 32 Hz flicker stimuli were recorded from a dilated eye over a range of stimulus intensities. B-wave amplitudes were compared to baseline amplitudes recorded at initial visit, and the resulting inter-visit percent difference was compared between stimulus intensities. Inter-visit variability was determined by one-way repeated measures analysis of variance using a 95% confidence interval to calculate threshold criteria for significant change. Analysis of variance followed by Bonferroni test for pairwise comparison was used to test for differences in inter-visit variability between two RP patient subgroups (higher versus lower baseline amplitudes) and visually normal subjects. The effect of stimulus intensity on amplitude reproducibility was also assessed.
RESULTS: Threshold for significant increase or decrease in inter-visit ERG amplitudes at a 95% confidence level for patients with RP and visually normal subjects was often at or above 25% and not infrequently at or above 40% for certain stimuli and test conditions. While no statistical difference in inter-visit variability was demonstrated between visually normal subjects and patients with RP who were arbitrarily categorized as having relatively higher baseline amplitudes, there was a difference between each of these two groups and a smaller group of patients with RP categorized as having lower baseline amplitudes. Although the authors could not demonstrate that percent inter-visit differences varied with stimulus intensity in either controls or patients with RP, the 32 Hz flicker stimulus generally produced less amplitude variability than either dark- or light-adapted single flash stimuli in patients with RP.
CONCLUSIONS: When using ERG amplitude for monitoring either the natural history of functional loss in retinal disease or as an outcome measure during a therapeutic trial, it becomes vital to define inter-visit variability of ERG amplitudes. These findings suggest that a percentage of patients with RP with appreciably lower baseline ERG amplitudes may manifest greater inter-visit ERG amplitude variability than patients with RP with higher baseline amplitudes or controls. Stimulus intensity had no clinically significant effect on inter-visit amplitude variability.

Entities:  

Mesh:

Year:  2005        PMID: 16340532     DOI: 10.1097/00006982-200512000-00010

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  23 in total

1.  Intrasession variability of the full-field ERG.

Authors:  Grant D Hochstein; Fanni E Molnar; Michael F Marmor
Journal:  Doc Ophthalmol       Date:  2007-05-09       Impact factor: 2.379

2.  Chapter 8 - Restoring Vision to the Blind: Evaluating Visual Function, Endpoints.

Authors: 
Journal:  Transl Vis Sci Technol       Date:  2014-12-30       Impact factor: 3.283

3.  Multi-centre variability of ISCEV standard ERGs in two normal adults.

Authors:  R Hamilton; A Al Abdlseaed; J Healey; M M Neveu; L Brown; D Keating; V A McBain; D Sculfor; D A Thompson
Journal:  Doc Ophthalmol       Date:  2015-02-27       Impact factor: 2.379

4.  Bilateral Concordance of the Fundus Hyperautofluorescent Ring in Typical Retinitis Pigmentosa Patients.

Authors:  Tharikarn Sujirakul; Richard Davis; Deniz Erol; Lijuan Zhang; Giuseppe Schillizzi; Leticia Royo-Dujardin; Sherry Shen; Stephen Tsang
Journal:  Ophthalmic Genet       Date:  2013-10-10       Impact factor: 1.803

5.  Patient-reported outcome measures in inherited retinal degeneration gene therapy trials.

Authors:  Gabrielle D Lacy; Maria Fernanda Abalem; David C Musch; Kanishka T Jayasundera
Journal:  Ophthalmic Genet       Date:  2020-02-26       Impact factor: 1.803

6.  Presentation of TRPM1-Associated Congenital Stationary Night Blindness in Children.

Authors:  Virginia Miraldi Utz; Wanda Pfeifer; Susannah Q Longmuir; Richard John Olson; Kai Wang; Arlene V Drack
Journal:  JAMA Ophthalmol       Date:  2018-04-01       Impact factor: 7.389

7.  Content generation for patient-reported outcome measures for retinal degeneration therapeutic trials.

Authors:  Gabrielle D Lacy; Maria Fernanda Abalem; Lilia T Popova; Erin P Santos; Gina Yu; Hanan Y Rakine; Julie M Rosenthal; Joshua R Ehrlich; David C Musch; K Thiran Jayasundera
Journal:  Ophthalmic Genet       Date:  2020-06-22       Impact factor: 1.803

8.  Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa.

Authors:  David G Birch; Kirsten G Locke; Yuquan Wen; Kelly I Locke; Dennis R Hoffman; Donald C Hood
Journal:  JAMA Ophthalmol       Date:  2013-09       Impact factor: 7.389

9.  Multimodal Imaging of Central Retinal Disease Progression in a 2-Year Mean Follow-up of Retinitis Pigmentosa.

Authors:  Tharikarn Sujirakul; Michael K Lin; Jimmy Duong; Ying Wei; Sara Lopez-Pintado; Stephen H Tsang
Journal:  Am J Ophthalmol       Date:  2015-07-09       Impact factor: 5.258

10.  Flash electroretinography: normative values with surface skin electrodes and no pupil dilation using a standard stimulation protocol.

Authors:  Eleftherios S Papathanasiou; Savvas S Papacostas
Journal:  Doc Ophthalmol       Date:  2007-07-04       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.